Effect of Perioperative IV Ibuprofen on Cerebral Oxygenation and Postoperative Cognition During O… (NCT07399184) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effect of Perioperative IV Ibuprofen on Cerebral Oxygenation and Postoperative Cognition During One-Lung Ventilation
54 participantsStarted 2026-02-15
Plain-language summary
This study compares the effects of ibuprofen administered during surgery and within the first 24 hours after surgery, versus no ibuprofen, on cerebral oxygenation, postoperative changes in consciousness (postoperative delirium and cognitive dysfunction), length of stay in the intensive care unit, and the incidence of postoperative pain, nausea, vomiting, and pruritus in patients undergoing lung lobectomy or segmentectomy using a closed (video-assisted) method (VATS - video-assisted thoracoscopic surgery), in whom one-lung ventilation is applied.
The aim of this study is to evaluate the effects of ibuprofen on cerebral oxygenation, postoperative cognitive changes, and delirium in patients undergoing one-lung ventilation.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged 18-75 years
* American Society of Anesthesiologists (ASA) Physical Status Classification System I-III
* Patients scheduled for lobectomy or segmentectomy via Video-Assisted Thoracic Surgery (VATS ) with one-lung ventilation
* New York Heart Association (NYHA) class I-II
* Patients who have been informed about the study and have provided written informed consent will be included.
Exclusion Criteria:
* Patients younger than 18 years or older than 75 years
* History of alcohol or substance abuse
* Patients with chronic NSAID use and/or NSAID use within the last 30 days, or NSAID allergy
* Allergy to other drugs used in the study (e.g., bupivacaine)
* ASA Physical Status IV-V
* Severe hearing, visual, or speech impairment
* Dementia, Alzheimer's disease, or psychiatric disorders (psychosis, bipolar disorder, schizophrenia)
* History of previous head trauma
* Chronic liver disease
* Pregnancy
* History of cerebrovascular disease
* Moderate-to-severe chronic obstructive pulmonary disease (COPD) (predicted FEV₁ \<50%)
* GFR \<60 mL/min/1.73 m²
* Patients who do not provide written informed consent
* Conditions that may cause inaccurate cerebral oximetry readings (subdural and/or extracranial hematoma, intracranial arteriovenous shunts, hyperbilirubinemia)
* Patients undergoing emergency surgery
* Patients in whom surgery is initiated as thoracotomy or converted to thoracotomy
* Patients unable to complete the preoperative MMSE (total score ≤24)…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Right and left intraoperative cerebral oxygenation values (rScO₂)